REFERENCES
1. MAVYRET [package insert]. North Chicago, IL; AbbVie lnc. 2. Hepatitis C questions and answers for health professionals. Centers for Disease Control and Prevention. Updated August 7, 2020. Accessed January 27, 2022. https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm 3. Ryerson AB, Schillie S, Barker LK, Kupronis BA, Wester C. Vital signs: newly reported acute and chronic hepatitis C cases—United States, 2009–2018. MMWR Morb Mortal Wkly Rep. 2020;69(14):399-404. doi:10.15585/mmwr.mm6914a2 4. Centers for Disease Control and Prevention. 2019 Viral Hepatitis Surveillance Report. Published July 2021. Accessed January 27, 2022. https://www.cdc.gov/hepatitis/statistics/2019surveillance/pdfs/2019HepSurveillanceRpt.pdf 5. Zibbell JE, Iqbal K, Patel RC, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years—Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012. MMWR Morb Mortal Wkly Rep. 2015;64(17):453-458. 6. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C. HCV guidance website. Updated September 29, 2021. Accessed January 1, 2022. https://www.hcvguidelines.org 7. Centers for Disease Control and Prevention. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep. 2013;62(18):362-365.
GLOSSARY OF TERMS
AASLD = American Association for the Study of Liver Diseases
ALT = alanine aminotransferase
APRI = aspartate aminotransferase (AST) to platelet ratio index
ART = antiretroviral therapy
CC = compensated cirrhotic
CDC = Centers for Disease Control and Prevention
CKD = chronic kidney disease
CPSFU = core population with sufficient follow-up
Cure = sustained virologic response (SVR12); HCV RNA <LLOQ at 12 weeks after the end of treatment
DAA = direct-acting antiviral
DCV = daclatasvir
EC50 = 50% effective concentration
GT = genotype
HBV = hepatitis B virus
HCV = hepatitis C virus
HMG-CoA = hydroxymethylglutaryl coenzyme A
IDSA = Infectious Diseases Society of America
ITT = intent to treat
LLOQ = lower limit of quantification
MAT = medication-assisted treatment
mITT = modified intent to treat
NC = non-cirrhotic
NS = nonstructural protein
OTC = over the counter
PI = protease inhibitor
PPI = proton pump inhibitor
PrEP = pre-exposure prophylaxis
PRS-TE = prior treatment experience with regimens containing interferon, pegylated interferon, ribavirin, and/or sofosbuvir, but no prior treatment experience with an NS5A inhibitor or HCV NS3/4A protease inhibitor
PWID = people who inject drugs
RBV = ribavirin
Relapse = HCV RNA ≥LLOQ after end-of-treatment response among subjects who completed treatment
RT-PCR = reverse transcription polymerase chain reaction
SOF = sofosbuvir
SVR = sustained virologic response
SVR12 = sustained virologic response 12 weeks after the end of treatment
TE = treatment experienced
TN = treatment naïve
TW4 = treatment week 4